110 related articles for article (PubMed ID: 30391671)
1. Dermatopontin inhibits papillary thyroid cancer cell proliferation through MYC repression.
Guo Y; Li H; Guan H; Ke W; Liang W; Xiao H; Li Y
Mol Cell Endocrinol; 2019 Jan; 480():122-132. PubMed ID: 30391671
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by α3β1 integrin-Rho GTPase signaling.
Fu Y; Feng MX; Yu J; Ma MZ; Liu XJ; Li J; Yang XM; Wang YH; Zhang YL; Ao JP; Xue F; Qin W; Gu J; Xia Q; Zhang ZG
Oncotarget; 2014 Aug; 5(16):6701-15. PubMed ID: 25149533
[TBL] [Abstract][Full Text] [Related]
3. MYC promotes the development of papillary thyroid carcinoma by inhibiting the expression of lncRNA PAX8‑AS1:28.
Zhang Y; Li F; Chen J
Oncol Rep; 2019 Apr; 41(4):2511-2517. PubMed ID: 30720110
[TBL] [Abstract][Full Text] [Related]
4. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
[TBL] [Abstract][Full Text] [Related]
5. Dermatopontin: a potential predictor for metastasis of human oral cancer.
Yamatoji M; Kasamatsu A; Kouzu Y; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Int J Cancer; 2012 Jun; 130(12):2903-11. PubMed ID: 21796630
[TBL] [Abstract][Full Text] [Related]
6. ANXA1 (Annexin A1) regulated by MYC (MYC proto-oncogene) promotes the growth of papillary thyroid carcinoma.
Ying X; Chen L; Xie J; Hu Y; Wu Q; Cao L; Yu H
Bioengineered; 2021 Dec; 12(2):9251-9265. PubMed ID: 34723715
[TBL] [Abstract][Full Text] [Related]
7. Dermatopontin is expressed in human liver and is downregulated in hepatocellular carcinoma.
Li X; Feng P; Ou J; Luo Z; Dai P; Wei D; Zhang C
Biochemistry (Mosc); 2009 Sep; 74(9):979-85. PubMed ID: 19916908
[TBL] [Abstract][Full Text] [Related]
8. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
[TBL] [Abstract][Full Text] [Related]
9. DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.
Ye D; Wang Y; Deng X; Zhou X; Liu D; Zhou B; Zheng W; Wang X; Fang L
Cell Death Dis; 2023 Feb; 14(2):106. PubMed ID: 36774339
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA BANCR regulates cancer stem cell markers in papillary thyroid cancer via the RAF/MEK/ERK signaling pathway.
Wang Y; Lin X; Fu X; Yan W; Lin F; Kuang P; Luo Y; Lin E; Hong X; Wu G
Oncol Rep; 2018 Aug; 40(2):859-866. PubMed ID: 29917164
[TBL] [Abstract][Full Text] [Related]
11. Effects of Dermatopontin gene silencing on apoptosis and proliferation of osteosarcoma MG‑63 cells.
Xi LC; Ji YX; Yin D; Zhao ZX; Huang SC; Yu SL; Liu BY; Li HY
Mol Med Rep; 2018 Jan; 17(1):422-427. PubMed ID: 29115446
[TBL] [Abstract][Full Text] [Related]
12. miR-214 regulates papillary thyroid carcinoma cell proliferation and metastasis by targeting PSMD10.
Liu F; Lou K; Zhao X; Zhang J; Chen W; Qian Y; Zhao Y; Zhu Y; Zhang Y
Int J Mol Med; 2018 Dec; 42(6):3027-3036. PubMed ID: 30272290
[TBL] [Abstract][Full Text] [Related]
13. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
14. Dermatopontin is a novel regulator of the CdCl2-induced decrease in claudin-11 expression.
Yang Q; Hao J; Chen M; Li G
Toxicol In Vitro; 2014 Sep; 28(6):1158-64. PubMed ID: 24909373
[TBL] [Abstract][Full Text] [Related]
15. TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57
Li X; Ruan X; Zhang P; Yu Y; Gao M; Yuan S; Zhao Z; Yang J; Zhao L
Oncogene; 2018 May; 37(21):2773-2792. PubMed ID: 29511350
[TBL] [Abstract][Full Text] [Related]
16. Dermatopontin in Bone Marrow Extracellular Matrix Regulates Adherence but Is Dispensable for Murine Hematopoietic Cell Maintenance.
Kramer AC; Blake AL; Taisto ME; Lehrke MJ; Webber BR; Lund TC
Stem Cell Reports; 2017 Sep; 9(3):770-778. PubMed ID: 28844660
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of dermatopontin and its implications for testicular dysfunction in mice.
Cai J; Liu W; Hao J; Chen M; Li G
Mol Med Rep; 2016 Mar; 13(3):2431-8. PubMed ID: 26861869
[TBL] [Abstract][Full Text] [Related]
18. Spatiotemporal expression of the dermatopontin gene in zebrafish Danio rerio.
Tan Y; Iimura K; Sato T; Ura K; Takagi Y
Gene; 2013 Mar; 516(2):277-84. PubMed ID: 23266816
[TBL] [Abstract][Full Text] [Related]
19. Role of dermatopontin in re-epithelialization: implications on keratinocyte migration and proliferation.
Krishnaswamy VR; Korrapati PS
Sci Rep; 2014 Dec; 4():7385. PubMed ID: 25486882
[TBL] [Abstract][Full Text] [Related]
20. MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma.
Ding C; Yu H; Shi C; Shi T; Qin H; Cui Y
Biomed Pharmacother; 2019 Feb; 110():528-536. PubMed ID: 30530288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
